Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_assertion type Assertion NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_head.
- NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_provenance.
- NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_assertion evidence source_evidence_literature NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_provenance.
- NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_assertion SIO_000772 17606710 NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_provenance.
- NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_assertion wasDerivedFrom befree-20140225 NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_provenance.
- NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_assertion wasGeneratedBy ECO_0000203 NP618115.RARD34TWg45PEN83rpUJ1E5-V3yd9ZjrjaUFxB4gJS5n4130_provenance.